SCHEMBL764317

SCHEMBL764317

Cc1ccc(CNc2ccc(C)cn2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.62
KDM4E B2RXH2 4/20 0.62
HPGD P15428 2/20 0.62
NPC1 O15118 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
MAPK1 P28482 2/20 0.49
RAB9A P51151 6/20 0.49
CXCR4 P61073 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48
MAPT P10636 5/20 0.47
KMT2A Q03164 5/20 0.46
MEN1 O00255 4/20 0.46
POLB P06746 2/20 0.46
GAA P10253 3/20 0.46
HSP90AA1 P07900 1/20 0.46
HSP90AB1 P08238 1/20 0.46
THRB P10828 1/20 0.46
ALOX15 P16050 1/20 0.46
CASP1 P29466 1/20 0.46
BLM P54132 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12832039 0.90 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDNPC1SMN1; SMN2
SCHEMBL11563242 0.90 KMT2A (0.60) ALDH1A1KDM4EHPGDNPC1SMN1; SMN2
SCHEMBL22602024 0.90 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDNPC1SMN1; SMN2
SCHEMBL11561740 0.90 POLB (0.60) ALDH1A1KDM4EHPGDNPC1SMN1; SMN2
SCHEMBL11563461 0.89 NOS2 (0.58) ALDH1A1KDM4EHPGDNPC1SMN1; SMN2
SCHEMBL13879786 0.88 CXCR4 (0.54) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL16001177 0.88 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDNPC1SMN1; SMN2
SCHEMBL18772850 0.87 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL3669945 0.87 NPC1 (0.63) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL11564368 0.84 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078015-B1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1 AND/OR NF-KAPPAB ACTIVITY AND USE THEREOF BRISTOL MYERS SQUIBB CO (US) 2012-03-21 EP disclosed
WO-2008057859-A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-I AND/OR NF-KAPPAB ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2008-05-15 WO disclosed
EP-0000816-A1 Substituted amino-pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1979-02-21 EP disclosed